Not yet recruitingObservationalLast updated Aug 7, 2026

VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY

VALIDATION OF THE FUSION CEMEP SCORE FOR THE OMISSION OF SYSTEMATIC PROSTATE BIOPSY IN PATIENTS UNDERGOING MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING-TARGETED BIOPSY

Overview

ClinicalTrials.gov ID: NCT07753356
Lead Sponsor: Marcelo Ruben OlivaOTHER
Brief Summary: This study aims to prospectively validate the Fusion CEMEP score to assess the safety and efficacy of omitting systematic prostate biopsy in patients undergoing multiparametric magnetic resonance imaging-targeted biopsy. The main objective is to determine if target-only biopsy guided by the score is sufficient for clinically significant prostate cancer detection while reducing overtreatment and unnecessary cores.

Status

Overall Status: Not yet recruiting
Start Date: Aug 15, 2026Estimated
Primary Completion Date: Dec 20, 2027Estimated
Completion Date: Dec 30, 2029Estimated

Study Record Dates

First Submitted: Aug 4, 2026
First Submitted that Met QC Criteria: Aug 4, 2026
First Posted: Aug 7, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 4, 2026
Last Update Posted: Aug 7, 2026Actual
Last Verified: Aug 2026

NCT05818631Unknown status

Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer

NCT05969704Completed

Fusion Versus Cognitive MRI Targeted Prostatic Biopsy

NCT07306741Recruiting

Cognitive and Fusion Prostatic Biopsy

NCT06517901Recruiting

Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer

NCT04953351Unknown status

MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate Biopsy

NCT02450266Unknown status

Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided Biopsy